Aurobindo Pharma (BOM:524804) Net Income (Continuing Operations) : ₹34,836 Mil (TTM As of Mar. 2025)

View and export this data going back to 1995. Start your Free Trial

What is Aurobindo Pharma Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Aurobindo Pharma's Net Income (Continuing Operations) for the three months ended in Mar. 2025 was ₹9,028 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹34,836 Mil.

Aurobindo Pharma Net Income (Continuing Operations) Historical Data

The historical data trend for Aurobindo Pharma's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurobindo Pharma Net Income (Continuing Operations) Chart

Aurobindo Pharma Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Net Income (Continuing Operations)

Get a 7-Day Free Trial

53,338.20

26,471.10

19,276.50

31,689.70

34,835.70

Aurobindo Pharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income (Continuing Operations)	Get a 7-Day Free Trial															9,073.50	9,182.20	8,169.50	8,455.70	9,028.30

Aurobindo Pharma Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹34,836 Mil.

Aurobindo Pharma (BOM:524804) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Aurobindo Pharma Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Aurobindo Pharma's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Aurobindo Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aurobindo Pharma Ltd (BOM:524804) » Definitions » Net Income (Continuing Operations)

Traded in Other Exchanges

AUROPHARMA:India

Address

Plot No. 1, Survey No. 83/1, Galaxy, Floors 22-24, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad, TG, IND, 500032

Website

https://www.aurobindo.com

Aurobindo Pharma Ltd is a specialty and generic drug manufacturing company. It is principally engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Its formulations target key therapeutic areas, including Central Nervous System (CNS), Antibiotics, Anti-diabetics, Cardiovascular, Anti-retroviral, Gastroenterology, Oncology, and Dermatology. The operating and reportable segments of the company are; India, the United States of America, Europe, and the Rest of the World. The company generates a majority of its revenue from its business in the United States of America.

Aurobindo Pharma Headlines

No Headlines